Xin Li1, Peter Kraft2, Immaculata De Vivo3, Edward Giovannucci4, Liming Liang2, Hongmei Nan5. 1. Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. 2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 3. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. 4. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 5. Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana; Department of Global Health, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana. Electronic address: hnan@iu.edu.
Abstract
BACKGROUND: Taller individuals are at higher risk of melanoma. OBJECTIVE: To prospectively investigate the association of height with nevus count and melanoma and estimate the proportion of height-melanoma association explained by nevus count among white participants from the Nurses' Health Study (NHS) and Nurses' Health Study 2 (NHS2). METHODS: We used Cox proportional hazards regression and multinomial logistic regression for data analyses, with adjustment of potential confounders in the multivariate model. RESULTS: We included 82,468 and 106,069 women from NHS and NHS2, respectively. The hazard ratio was 1.21 (95% confidence interval [CI] 1.12-1.31) for the association between every 10-cm increase in height and melanoma. Compared with women with no nevi, the odds ratios (95% CIs) associated with a 10-cm increase in height were 1.35 (95% CI 1.23-1.48) in the NHS and 1.12 (95% CI 1.09-1.15) in the NHS2 for women with greater than or equal to 10 moles. The proportion of excess melanoma risk associated with each 10-cm increase in height explained by nevus count was 8.03% in the NHS and 10.22% in the NHS2. LIMITATION: Self-reported height and nevus count. Mole counts were limited to 1 arm or both legs. CONCLUSION: Nevus count is an important explanatory factor for the excess risk of melanoma among taller white women.
BACKGROUND: Taller individuals are at higher risk of melanoma. OBJECTIVE: To prospectively investigate the association of height with nevus count and melanoma and estimate the proportion of height-melanoma association explained by nevus count among white participants from the Nurses' Health Study (NHS) and Nurses' Health Study 2 (NHS2). METHODS: We used Cox proportional hazards regression and multinomial logistic regression for data analyses, with adjustment of potential confounders in the multivariate model. RESULTS: We included 82,468 and 106,069 women from NHS and NHS2, respectively. The hazard ratio was 1.21 (95% confidence interval [CI] 1.12-1.31) for the association between every 10-cm increase in height and melanoma. Compared with women with no nevi, the odds ratios (95% CIs) associated with a 10-cm increase in height were 1.35 (95% CI 1.23-1.48) in the NHS and 1.12 (95% CI 1.09-1.15) in the NHS2 for women with greater than or equal to 10 moles. The proportion of excess melanoma risk associated with each 10-cm increase in height explained by nevus count was 8.03% in the NHS and 10.22% in the NHS2. LIMITATION: Self-reported height and nevus count. Mole counts were limited to 1 arm or both legs. CONCLUSION: Nevus count is an important explanatory factor for the excess risk of melanoma among taller white women.
Authors: Xin Li; Hongliang Liu; Christopher I Amos; Jeffrey E Lee; Nancy E Thomas; Qingyi Wei; Jiali Han Journal: Int J Cancer Date: 2017-06-08 Impact factor: 7.396
Authors: Catherine M Olsen; Adèle C Green; Michael S Zens; Therese A Stukel; Veronique Bataille; Marianne Berwick; J Mark Elwood; Richard Gallagher; Elizabeth A Holly; Connie Kirkpatrick; Thomas Mack; Anne Østerlind; Stefano Rosso; Anthony J Swerdlow; Margaret R Karagas Journal: Int J Cancer Date: 2008-03-01 Impact factor: 7.396
Authors: Oliver Clewes; Alla Narytnyk; Kevin R Gillinder; Andrew D Loughney; Alison P Murdoch; Maya Sieber-Blum Journal: Stem Cell Rev Rep Date: 2011-11 Impact factor: 5.739
Authors: Trang VoPham; Jaime E Hart; Kimberly A Bertrand; Zhibin Sun; Rulla M Tamimi; Francine Laden Journal: Environ Health Date: 2016-11-24 Impact factor: 5.984
Authors: David L Duffy; Gu Zhu; Xin Li; Marianna Sanna; Mark M Iles; Leonie C Jacobs; David M Evans; Seyhan Yazar; Jonathan Beesley; Matthew H Law; Peter Kraft; Alessia Visconti; John C Taylor; Fan Liu; Margaret J Wright; Anjali K Henders; Lisa Bowdler; Dan Glass; M Arfan Ikram; André G Uitterlinden; Pamela A Madden; Andrew C Heath; Elliot C Nelson; Adele C Green; Stephen Chanock; Jennifer H Barrett; Matthew A Brown; Nicholas K Hayward; Stuart MacGregor; Richard A Sturm; Alex W Hewitt; Manfred Kayser; David J Hunter; Julia A Newton Bishop; Timothy D Spector; Grant W Montgomery; David A Mackey; George Davey Smith; Tamar E Nijsten; D Timothy Bishop; Veronique Bataille; Mario Falchi; Jiali Han; Nicholas G Martin Journal: Nat Commun Date: 2018-11-14 Impact factor: 14.919